Correlation Between Karyopharm Therapeutics and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and Lyra Therapeutics, you can compare the effects of market volatilities on Karyopharm Therapeutics and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Lyra Therapeutics.
Diversification Opportunities for Karyopharm Therapeutics and Lyra Therapeutics
0.5 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Karyopharm and Lyra is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Karyopharm Therapeutics and Lyra Therapeutics
Given the investment horizon of 90 days Karyopharm Therapeutics is expected to generate 0.75 times more return on investment than Lyra Therapeutics. However, Karyopharm Therapeutics is 1.34 times less risky than Lyra Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 71.00 in Karyopharm Therapeutics on September 26, 2024 and sell it today you would lose (11.00) from holding Karyopharm Therapeutics or give up 15.49% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Karyopharm Therapeutics vs. Lyra Therapeutics
Performance |
Timeline |
Karyopharm Therapeutics |
Lyra Therapeutics |
Karyopharm Therapeutics and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Karyopharm Therapeutics and Lyra Therapeutics
The main advantage of trading using opposite Karyopharm Therapeutics and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Lyra Therapeutics vs. Fate Therapeutics | Lyra Therapeutics vs. Caribou Biosciences | Lyra Therapeutics vs. Karyopharm Therapeutics | Lyra Therapeutics vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |